ReviewAustralian prescriber2025
Sun protection: a practical guide for health professionals.
Review in Australian prescriber, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Sunscreen, vitamin D and skin of colour.Australian prescriber · 2026Article
- Familial melanoma: genetic, clinical, and dermoscopic insights and follow-up.Frontiers in medicine · 2026Review
Corrections and comments
- Commented on by
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cumulative exposure to ultraviolet radiation drives skin cancer and photo-ageing across all skin types, including people with darker skin. Visible light radiation plays a key role in the pathogenesis of pigmentary conditions. Intense childhood exposure to ultraviolet radiation is a critical risk factor for development of melanoma later in life. Effective sun protection requires a daily, multifaceted approach when the ultraviolet index is 3 or higher. This includes the correct application of broad-spectrum sunscreen with a sun protection factor of 50+ in conjunction with protective clothing, a broad-brimmed hat, sunglasses, and seeking shade. Some medicines may be photosensitising and patients using these medicines should be advised to adopt stricter sun protection measures. There are many myths about sunscreens that may be barriers to sunscreen use, including concerns about endocrine disruption and nanoparticle toxicity. When counselling patients on sun protection, it is important to offer practical, evidence-based advice that extends beyond sunscreen use alone. The goal is to empower patients to incorporate sun safety into their daily routines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.